NCT04020380View on ClinicalTrials.gov

Azithromycin a Treatment for Pulmonary Sarcoidosis

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 6, 2019

Primary Completion Date

June 20, 2020

Study Completion Date

June 20, 2020

Conditions
Sarcoidosis, Pulmonary
Interventions
DRUG

Azithromycin 250Mg Capsule

250 mg OD

Trial Locations (1)

HU16 5JQ

Respiratory Medicine Clinical trials Unit, Cottingham

All Listed Sponsors
lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT04020380 - Azithromycin a Treatment for Pulmonary Sarcoidosis | Biotech Hunter | Biotech Hunter